Cholib 145 mg/40 mg FILM-COATED TABLETS

2. What you need to know before you take Cholib

Do not take Cholib:

• if you are allergic to fenofibrate or simvastatin or any of the other ingredients of Cholib (listed in section 6)

• if you are allergic to peanuts, peanut oil, soy lecithin, or related substances

• if you have had an allergic reaction or skin lesions caused by sunlight or UV light while taking other medications (including other fibrates and an anti-inflammatory medication called "ketoprofen")

• if you have liver or gallbladder problems

• if you have pancreatitis (inflamed pancreas that causes abdominal pain), which is not caused byhigh levels of fat in the blood

• if you have moderate or severe kidney problems.

• if you have a history of muscle problems during treatment to reduce fat levels in the blood with either of the active substances of this medicine or with other statins (such as atorvastatin, pravastatin, or rosuvastatin) or fibrates (such as bezafibrate or gemfibrozil)

• if you are already taking the following medications:

• danazol (an artificial hormone used to treat endometriosis)

• cyclosporine (a medication commonly used in patients who have undergone organ transplants)

• itraconazole, ketoconazole, fluconazole, or posaconazole (medications for fungal infections)

• HIV protease inhibitors such as indinavir, nelfinavir, ritonavir, and saquinavir (medications used in HIV and AIDS infection)

• erythromycin, clarithromycin, or telithromycin (medications for bacterial infections)

• nefazodone (a medication for depression)

• amiodarone (a medication for heart rhythm disorders) or verapamil (a medication used for high blood pressure, chest pain associated with heart disease, and other heart conditions)
• antiviral agents for hepatitis C such as elbasvir, grazoprevir, glecaprevir, or pibrentasvir (used to treat hepatitis C virus infection)

• if you are already undergoing treatment and will continue treatment with:

• a fibrate (e.g., gemfibrozil)

• a statin (a medication to reduce fat levels in the blood, e.g., simvastatin, atorvastatin)

• if you are under 18 years old

• if you are pregnant or breastfeeding

Do not take Cholib if any of the above situations apply to you. If in doubt, consult your doctor or pharmacist again.

Warnings and precautions:

Consult your doctor or pharmacist before taking Cholib if:

• you have an underactive thyroid gland (hypothyroidism)

• you are scheduled to undergo surgery. You may need to stop taking Cholib for a short period.

• you drink large amounts of alcohol (more than 21 units (210 ml) of pure alcohol per week)

• you experience chest pain and difficulty breathing. These may be signs of a blood clot in the lung (pulmonary embolism)

• you have severe lung disease

• you have kidney disease

• you or a close relative have a hereditary muscle problem

• you are taking or have taken in the last 7 days a medication called fusidic acid (an antibiotic)

• you are taking antiviral agents for hepatitis C such as elbasvir or grazoprevir (used to treat hepatitis C virus infection)

If any of the above situations apply to you, consult your doctor or pharmacist before taking Cholib. If in doubt, consult your doctor or pharmacist again.

Also, inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and medication may be necessary to diagnose and treat this problem.

Your doctor will perform a blood test before you start taking Cholib to check how well your liver is working.

Your doctor may also want to perform blood tests to check how well your liver is working after you start taking Cholib.

While taking this medication, your doctor will closely monitor you if you have diabetes or are at risk of developing the disease. You are likely to be at risk of developing diabetes if you have high levels of sugar and fat in your blood, are overweight, and have high blood pressure.

Your doctor may perform a blood test to check your muscles before and after starting treatment.

Children and adolescents

Cholib should not be given to children or adolescents (under 18 years old).

Taking Cholib with other medicines:

It is especially important that you inform your doctor or pharmacist if you are taking, have recently taken, or might take other medicines. This also applies to medicines without a prescription, including herbal medicines.

Inform your doctor or pharmacist if you are taking any of the following medications:

1. danazol (an artificial hormone used to treat endometriosis)

1. cyclosporine (a medication commonly used in patients who have undergone organ transplants)

organs)

1. itraconazole, ketoconazole, fluconazole, or posaconazole (medications for fungal infections) or HIV protease inhibitors such as indinavir, nelfinavir, ritonavir, and saquinavir

(medications used in HIV and AIDS infection)

or elbasvir, grazoprevir, glecaprevir, or pibrentasvir (used to treat hepatitis C virus infection)

or erythromycin, clarithromycin, or telithromycin (medications for bacterial infections) or nefazodone (a medication for depression)

or amiodarone (a medication for heart rhythm disorders) or verapamil (a medication used for high blood pressure, chest pain associated with heart disease, and other heart conditions)

or a fibrate (e.g., fenofibrate, gemfibrozil)

1. a statin (e.g., simvastatin, atorvastatin)

Do not take Cholib if any of the above situations apply to you. If in doubt, consult your doctor or pharmacist again.

In particular, inform your doctor or pharmacist if you are taking any of the following medications (taking Cholib with any of these medications may increase the risk of muscle problems):

• high doses of at least 1 gram per day of niacin (nicotinic acid) or a treatment that contains niacin (a medication to reduce fat levels in the blood)

• colchicine (a medication used to treat gout)

Do not take fusidic acid (an antibiotic) while using this medication.

Apart from the medications mentioned above, inform your doctor or pharmacist if you are taking, have recently taken, or might take any of the following medications:

• anticoagulants such as warfarin, fluindione, phenprocoumon, or acenocoumarol (medications to prevent blood clots)

• pioglitazone (a particular class of medications for treating diabetes)

• rifampicin (a medication used to treat tuberculosis)

If any of the above situations apply to you, consult your doctor or pharmacist before taking Cholib. If in doubt, consult your doctor or pharmacist again.

Cholib with food and drinks

Grapefruit juice contains one or more components that alter the way the body uses Cholib. Do not take grapefruit juice with Cholib, as it may increase your risk of muscle problems.

Pregnancy and breastfeeding

• Do not take Cholib if you are pregnant, trying to become pregnant, or think you may be pregnant. If you become pregnant while taking Cholib, stop taking it immediately and consult your doctor.

• Do not take Cholib if you are breastfeeding or planning to breastfeed, as it is unknown whether the medication passes into breast milk.

If you are pregnant, breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and using machines:

Cholib is not expected to affect your ability to drive or use tools or machines. However, you should be aware that some people may feel dizzy after taking Cholib.

Important information about some of the ingredients of Cholib

Cholib contains types of sugars called lactose and sucrose. If your doctor has told you that you have an intolerance to some sugars, talk to them before taking this medication.

Cholib contains soy lecithin. If you are allergic to peanuts, soy, or peanut oil, do not use Cholib.

3. How to take Cholib

Follow the instructions for administration of this medicine exactly as prescribed by your doctor.

In case of doubt, consult your doctor or pharmacist again.

Your doctor will determine the appropriate dose for you based on your condition, current treatment, and personal risk factors.

The usual dose is one tablet per day.

You can take Cholib with or without food.

The tablets should be swallowed with a glass of water.

The tablets should not be crushed or chewed.

You should follow a low-fat diet or take other measures (e.g., exercise, weight loss) while taking Cholib.

If you take more Cholib than you should

If you have taken more Cholib than you should or if someone else has taken your medicine, inform your doctor or pharmacist or contact the nearest hospital.

If you forget to take Cholib

Do not take a double dose to make up for forgotten tablets. Take the next tablet at the usual time the next day. If you are concerned, consult your doctor or pharmacist.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

• Any muscle pain, pain on palpation, or unexplained weakness may be a sign of muscle degradation. Therefore, if you develop any of these symptoms, inform your doctor immediately, as in rare cases, serious muscle problems have occurred, including muscle degradation that causes kidney damage; and very rare deaths have occurred. Compared to a fibrate or statin taken alone, the risk of muscle degradation increases when taking these 2 medicines together, as is the case with Cholib. It is higher in women or patients over 65 years old.

Some patients have experienced the following serious adverse effects while taking fenofibrate or simvastatin (both active ingredients of Cholib):

• hypersensitivity reactions (allergic) including: swelling of the face, tongue, and throat, which can cause difficulty breathing (angioedema) (rare)

• a severe allergic reaction that causes difficulty breathing or dizziness (anaphylactic reaction) (very rare)

• hypersensitivity reaction to Cholib with symptoms such as: pain or inflammation of the joints, inflammation of the blood vessels, unusual bruising, swelling, and skin rash, hives, skin sensitivity to sunlight, fever, hot flashes, difficulty breathing, and feeling of discomfort, symptoms of a disease similar to lupus (including rash, joint disorders, and effects on white blood cells)

• cramps or pain, discomfort, or muscle weakness, muscle rupture: these can be signs of inflammation or muscle degradation, which can cause kidney damage or even death

• stomach pain: may be a sign that your pancreas is inflamed (pancreatitis)

• chest pain and difficulty breathing: these can be signs of a blood clot in the lung (pulmonary embolism)

• pain, redness, or swelling of the legs: may be signs of a blood clot in the leg (deep vein thrombosis)

• yellow color of the skin and the whites of the eyes (jaundice) or an increase in liver enzymes: may be signs of an inflamed liver (hepatitis and liver failure)

• increased sensitivity of the skin to sunlight, sunlamps, and tanning beds

• rash that can occur on the skin or ulcers in the mouth (drug-induced lichenoid eruptions)

If you experience any of the serious adverse effects listed above, stop taking Cholib and inform your doctor immediately or go to the emergency department of the nearest hospital; you may need urgent medical treatment.

Some patients have experienced the following adverse effects while taking Cholib, fenofibrate, or simvastatin:

Very frequent adverse effects (may affect more than 1 in 10 people):

• increase in "creatinine" level in the blood (substance excreted by the kidneys)

• increase in blood levels of "homocysteine" (an excessive amount of this amino acid in the blood is related to a higher risk of coronary heart disease, stroke, and peripheral vascular disease, although a causal relationship has not been established)

Frequent adverse effects (may affect up to 1 in 10 people):

• increase in platelet count in blood

• elevations in blood tests of liver function (transaminases)

• digestive disorders (stomach pain, nausea, vomiting, diarrhea, and flatulence)

• upper respiratory tract infection

Uncommon adverse effects (may affect up to 1 in 100 people):

• muscle problems

• gallstones

• rash, itching, red spots on the skin

• headache

• sexual problems

Rare adverse effects (may affect up to 1 in 1,000 people):

• low red blood cell count (anemia)

• numbness or weakness of arms and legs

• confusion

• dizziness

• feeling of exhaustion (asthenia)

• increase in "urea" (produced by the kidneys) reflected in tests

• increase in "gamma glutamyltransferase" (produced by the liver) reflected in tests

• increase in "alkaline phosphatase" (produced by the biliary system) reflected in tests

• increase in "creatine phosphokinase" (produced by muscle) reflected in tests

• decrease in hemoglobin (which transports oxygen in the blood) and white blood cells - reflected in tests

• sleep disorders

• deficient or lost memory

• hair loss

• constipation

• dyspepsia

• blurred vision and vision deterioration

Very rare adverse effects (may affect up to 1 in 10,000 people):

• gynecomastia (breast enlargement in men)

The following adverse effects have also been reported, but their frequency cannot be estimated from the available data (frequency not known):

• severe allergic skin rash with blisters

• complications of gallstones such as colic, caused by the presence of stones in the bile duct, infection of the bile ducts or gallbladder

• diabetes mellitus

• erectile dysfunction

• feeling of depression

• sleep disorders, including nightmares

• specific lung disease with breathing difficulties (called interstitial lung disease)

• constant muscle weakness

• increase in "glycosylated hemoglobin" and blood glucose levels (markers of blood glucose control in diabetes mellitus) reflected in tests

Reporting of Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report it directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Cholib

Keep this medicine out of the sight and reach of children.

Do not use Cholib after the expiration date that appears on the box and blister after CAD.

The expiration date is the last day of the month indicated.

Store below 30 °C.

Medicines should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Cholib

The active ingredients are fenofibrate and simvastatin. Each tablet contains 145 mg of fenofibrate and 40 mg of simvastatin.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e., it is essentially "sodium-free".

The other ingredients are:

Core of the tablet:

Butylhydroxyanisole (E320), lactose monohydrate, sodium lauryl sulfate, pregelatinized corn starch, sodium docusate, sucrose, citric acid monohydrate (E330), hypromellose (E464), crospovidone (E1202), magnesium stearate (E572), silicified microcrystalline cellulose (composed of microcrystalline cellulose and anhydrous colloidal silicon dioxide), ascorbic acid (E300).

Coating:

Partially hydrolyzed polyvinyl alcohol (E1203), titanium dioxide (E171), talc (E553b), soybean lecithin (E322), xanthan gum (E415), red iron oxide (E172).

Appearance of Cholib and Package Contents

Tablet coated with a film, oval, biconvex, brick-red in color, with the inscription 145/40 on one side. The diameter is approximately 19.3 x 9.3 mm and the weight of the tablet is approximately 840 mg.

The tablets are presented in cardboard boxes with blisters containing 10, 30, or 90 tablets.

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Mylan IRE Healthcare Ltd, Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 – Ireland.

Manufacturer:

Mylan Laboratories SAS, Route de Belleville - Lieu-dit Maillard, 01400 Châtillon-sur-Chalaronne - France.

Mylan Hungary Kft., Mylan utca 1, Komárom 2900, Hungary

You can request more information about this medicine by contacting the local representative of the marketing authorization holder.

Date of the Last Revision of this Prospectus: Other Sources of Information

Detailed information about this medicine is available on the website of the European Medicines Agency (EMA): http://www.ema.europa.eu.